Organisation involving high tech, life sciences and biotech

Austrianova is one company that does businesses that contains high tech, life sciences and biotech. It is combined with an encapsulation technology with the living cells in bio-inery polymers. In short, we are a life science congregatedcombined company that specialises in the enclosure of living cells or bacteria in small capsules for protection which is also known as cell encapsulation technology, isolation, storage and transportation. We were first formed in the year 2007 and was based in Singapore's well-known investigation biotech hub, Biopolis that has international footprint in providing encapsulation facilities like micro encapsulation.

There is a speedy moving matter of passion in healthy repair and more exact, in the matter of neutraceuticals which is the learning and use of probiotic bacteria. So, probiotics encapsulation was built. The cell-in-a-box technology was developed by Austranova with the goal to defend, cut off, collect and move living cells. This advanced skill can be used for many purposes and can be joined to probiotics, cosmetics and agriculture environmental protection and screening as well as forming the foundation of a controlling exploration device.

In healthcare, this technology assists controloperate safe attaching of cells or stem cells such as cell therapy, combining them separated from the immune system and allowing long period making of therapeutic molecules in patients. In biotechnology, the cell-in-a-box procedure defends cells in bioreactors and fermentors and at the same time, it simplifies cleansing of bioproducts created from the cells and it shorten making rate too.

A huge gauge cGMP facility for the construction of biomedical grade encapsulated cell items was actually successfully constructed and right now, Austrianova is in the journey of setting up this skill in the whole of SE Asia. This means the use of cell-in-a-box was quite a success for ancreatic cancer! Basically, it is the use of encapsulated cells for cancer cell therapy from genetically modified cells over-expressing a chemo-activating enzyme to permit lesser dosages of chemotherapy to be used more efficaciously without the normal devastating side results. The encapsulated cell are sited, using supraselective catheterisation, into blood vessels that flows to the tumor where they locally change a chemotherapeutic product to its tumor toxic product.

Visit our site for more details: Capsules, Stem Cells , Encapsulation Technology.